Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis

BACKGROUND: Orally administered fluralaner (13.64% w/w) is effective for treating canine generalized demodicosis. A study was initiated to assess the efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation for monthly administration in the treatment of this disease. METHODS: Client-owne...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohdich, Nadja, Meyer, Leon, Guerino, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917636/
https://www.ncbi.nlm.nih.gov/pubmed/35279216
http://dx.doi.org/10.1186/s13071-022-05213-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917636/
https://www.ncbi.nlm.nih.gov/pubmed/35279216
http://dx.doi.org/10.1186/s13071-022-05213-x

Ejemplares similares